Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma (MREO) Interest & Investment Income (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Interest & Investment Income for 3 consecutive years, with $421000.0 as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income fell 52.21% to $421000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, down 28.52% year-over-year, with the annual reading at $2.2 million for FY2025, 28.54% down from the prior year.
  • Interest & Investment Income for Q4 2025 was $421000.0 at Mereo BioPharma, down from $504000.0 in the prior quarter.
  • The five-year high for Interest & Investment Income was $983000.0 in Q3 2024, with the low at $306000.0 in Q1 2023.
  • Average Interest & Investment Income over 3 years is $612000.0, with a median of $603000.0 recorded in 2024.
  • The sharpest move saw Interest & Investment Income skyrocketed 101.63% in 2024, then crashed 52.21% in 2025.
  • Over 3 years, Interest & Investment Income stood at $763000.0 in 2023, then increased by 15.47% to $881000.0 in 2024, then plummeted by 52.21% to $421000.0 in 2025.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $421000.0, $504000.0, and $589000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.